Charlie Strunck

Director of Market Access Oncology-Solid Tumor Franchise at BeOne Medicines USA, Inc.

Speaker

Charlie Strunck is Senior Director, Market Access – TEVIMBRA Solid Tumor at BeOne Medicines. With more than 28 years of experience in oncology, market access, reimbursement, and patient support, he is dedicated to improving access to innovative therapies and reducing barriers to care. Throughout his career, Charlie has held leadership roles at Novartis, GSK, Cencora, Soleo Health, UCB, and Bristol Myers Squibb, partnering with providers, payers, and health systems to advance patient-centered access solutions. He resides in Grapevine with his wife, Nicole, and their two dogs.